A botanically derived, non-opioid pain treatment made from cannabis is moving through regulatory review in Europe and the United States, adding to growing evidence that supported the FDA’s 2024 ...

"Year to date" sales for 2023, 2024, 2025, and 2026 sales are shown in series at the top of the table and then just below a comparison of 2026 versus 2025 and 2026 versus 2024 is displayed. This ...

Ten years after the publication of the 2016 CDC opioid guideline, enough time has passed to examine what followed. Consider this a biopsy of a decade of American pain policy—not an examination of what ...

Overview Three recent congressional proposals — the 340B for Patients Act, the SECURE 340B Act, and the SUSTAIN 340B Act — ...

The past several years saw muted IPO activity, a generally negative signal for market health. But 2026 has reversed that trend. Yes, you can say that the June IPO of SpaceX, the largest ever public ...

The Trump administration's lethal campaign against "drug boats" is back, marijuana arrests topped 200,000 last year, and more. More Than 200,000 People Arrested for Pot Possession Last Year. The FBI ...

TYLENOL®, the #1 doctor-recommended pain relief brand, will present compelling research data supporting the clinical efficacy of TYLENOL® with Naproxen at the 20th Annual PAINWeek Conference in Las ...

The final outcome of the Rights Issue is expected to be announced around 22 September 2026. Paid subscribed shares (BTA) will be traded on Nasdaq First North Growth Market until the new shares have ...

Albertsons Companies faces ongoing market share loss and margin compression, with shares down 70% from 2022 highs. Learn more on ACI stock here.

Plus, Phoebe Bridgers earns her first solo top 10 with Lost Weekend bowing at No. 2. By Keith Caulfield KATSEYE lands its first No. 1 album on the Billboard 200 as WILD debuts atop the list (dated Aug ...

Ewan McGregor and Anne Hathaway in "The End of Oak Street." Warner Bros. Pictures It's been a busy year for Anne Hathaway at ...